VitaLonga

Longevity education

Stay curious about aging well — without pretending to be your clinician.

Read today's research headlines, run honest calculators, keep a private record, and assemble an educational supplement protocol. Not a clinic.

A couple walking a sunlit woodland path

Latest news

Newest story: 13 Nov 2026

News archive →

Nature Aging · 13 Nov 2026 · Aging

During sleep, cerebrospinal fluid waves rose less in older adults than in young adults

A sleep imaging study was published online on 13 November 2026 in Nature Aging. Bailes, Williams, Lewis, and colleagues scanned people with fMRI and EEG. The sleep group was young adults aged 18 to 39 (n=31) and older adults aged 60 to 84 (n=41). The paper does not give a sex split. From wake to NREM sleep, low-frequency cerebrospinal fluid power rose by an average of 3.82 dB in the young group and 1.15 dB in the older group (P=0.002). The age-by-state interaction was P=0.025. The rise was clear within the young group (P=0.005) and not within the older group (P=0.354). During NREM, the older group sat below the young group (P<0.001). During wake the gap was smaller (P=0.034). Gray-matter blood-oxygen signal power rose 3.67 dB in young adults and 2.15 dB in older adults (P=0.038), with an age-by-stage interaction of P=0.021. Within sleep, that older-versus-young gap was P=0.003. The two signals still moved together (r=0.75, n=25 young; r=0.78, n=32 older). The peak cross-correlation was 0.67 (n=30 young) versus 0.42 (n=38 older), a difference of 0.25 (P<0.001). The authors tie the pattern to neural and cerebrovascular changes, in the context of brain health, before clinical disease. This is an observational scan study, not a treatment test. DOI 10.1038/s43587-026-01270-4. Not medical advice.

Read at Nature Aging →Our summary♡ Save

  • study
  • sleep
  • cognition

European Heart Journal: Cardiovascular Pharmacotherapy · 13 Nov 2026 · Research

Statin-ezetimibe lined up with fewer myocardial infarctions than statin use alone in a Korean records study

A target-trial emulation was published online on 13 November 2026. It used Korean national insurance records. Adults aged 30 to 74 with dyslipidemia were compared after 180 days of statin use alone or a fixed statin-ezetimibe combination. The combination group had 309,371 people: 239,954 in an early cardiovascular-kidney-metabolic risk band and 69,417 in a late band. The abstract does not give a sex split. After weighting, the myocardial infarction hazard ratio was 0.87 (95 percent CI 0.81 to 0.95) in the early band and 0.88 (95 percent CI 0.79 to 0.98) in the late band, versus statin use alone. The 10-year weighted cumulative incidence was 1.97 percent versus 2.23 percent in the early band, and 3.52 percent versus 3.94 percent in the late band. The association was strongest for moderate-intensity statins, especially in the early band (hazard ratio 0.87, 95 percent CI 0.79 to 0.95). This is an association in records. It is not a guide to change a statin. DOI 10.1093/ehjcvp/pvag099. Not medical advice.

Read at European Heart Journal: Cardiovascular Pharmacotherapy →Our summary♡ Save

  • study

Nutrients · 13 Nov 2026 · Nutrition

In 326 older adults, two years of a walnut diet had little effect on body fat

A two-year randomized diet trial was published on 13 November 2026. The Walnuts and Healthy Aging trial ran in Barcelona and Loma Linda. This report covers 326 people from the Barcelona site, ages 63 to 79, including 220 women. They are older adults. The abstract does not limit the cohort to one sex. One group ate a diet with walnuts at 15 percent of daily energy. The other ate a control diet with no walnuts. Dual-energy X-ray scans tracked body weight, body fat, and fat-free mass. After two years, total and android fat rose, and gynoid fat and fat-free mass fell, in both sexes and both groups. Walnut versus control showed no clear difference, except a small rise in the android-to-gynoid ratio among women. On the walnut diet only, men with FTO-rs1861868 CC showed adverse composition changes versus T carriers, and that cell was small. APOE genotype did not change the result. The authors describe little effect on adiposity. A diet comparison, not a product test. DOI 10.3390/nu18223779. Not medical advice.

Read at Nutrients →Our summary♡ Save

  • study
  • aging

Daily Brief podcast

VitaLonga Daily Brief — November 14, 2026

November 14, 2026 · 19:54

All episodes →
Watch the video

Health sync

Get the app. Sync your watch, play the Daily Brief.

Install VitaLonga Sync, allow Apple Health or Health Connect, then scan the QR on Tracker with your phone camera. The Daily Brief keeps playing with the screen locked. File import stays as a fallback. Educational numbers only — not medical advice.

Cooking a colourful, healthy meal at home

Build your protocol

A rule-based stack from your profile, calculators, and recent tracker averages — with a why for every item.

Open protocol

Your week

Activity and exercise from your synced phone, last 7 days.

Stats →

Sign in to see your steps, sleep and workouts here.

Your protocol

A rule-based supplement stack built from your record. Educational, not a prescription.

Protocol →

Sign in and fill in your record to get a stack with a reason for every line.